Search research articles
Contact Us
Filters
Showing results (811-820 of 851) with videos related to
Page
of 86
Sort By:
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
Concordant transcriptional and morphological remodeling revealed by <i>in vivo</i> Perturb-CLEAR
Boli Wu, Sean K Simmons, Seoyeon Kim, et al.
Trials
|
April 25, 2019
Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)
Helen Blackshaw, Jane Vennik, Carl Philpott, et al.
Contemporary Clinical Trials
|
December 15, 2022
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers
Sophie Merrick, Matthew Nankivell, Matteo Quartagno, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 9, 2011
Discovery, optimisation and in vivo evaluation of novel GPR119 agonists
Katy J Brocklehurst, Anders Broo, Roger J Butlin, et al.
The New England Journal of Medicine
|
September 29, 2021
Maintenance or Discontinuation of Antidepressants in Primary Care
Gemma Lewis, Louise Marston, Larisa Duffy, et al.
BMJ Open
|
April 5, 2023
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol
Aqua Asif, Arjun Nathan, Alexander Ng, et al.
The Journal of Biological Chemistry
|
February 25, 2023
Gβγ subunits colocalize with RNA polymerase II and regulate transcription in cardiac fibroblasts
Shahriar M Khan, Ryan D Martin, Andrew Bayne, et al.
Health Technology Assessment (Winchester, England)
|
November 29, 2021
Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT
Larisa Duffy, Caroline S Clarke, Gemma Lewis, et al.
Journal of Medicinal Chemistry
|
October 7, 2014
Circumventing seizure activity in a series of G protein coupled receptor 119 (GPR119) agonists
James S Scott, Suzanne S Bowker, Katy J Brocklehurst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2020
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial
P Grimison, A Mersiades, A Kirby, et al.
Page
of 86
Search research articles
Search
Showing results (811-820 of 851) with videos related to
Sort By:
Page
of 86
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
Concordant transcriptional and morphological remodeling revealed by <i>in vivo</i> Perturb-CLEAR
Boli Wu, Sean K Simmons, Seoyeon Kim, et al.
Trials
|
April 25, 2019
Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)
Helen Blackshaw, Jane Vennik, Carl Philpott, et al.
Contemporary Clinical Trials
|
December 15, 2022
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers
Sophie Merrick, Matthew Nankivell, Matteo Quartagno, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 9, 2011
Discovery, optimisation and in vivo evaluation of novel GPR119 agonists
Katy J Brocklehurst, Anders Broo, Roger J Butlin, et al.
The New England Journal of Medicine
|
September 29, 2021
Maintenance or Discontinuation of Antidepressants in Primary Care
Gemma Lewis, Louise Marston, Larisa Duffy, et al.
BMJ Open
|
April 5, 2023
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol
Aqua Asif, Arjun Nathan, Alexander Ng, et al.
The Journal of Biological Chemistry
|
February 25, 2023
Gβγ subunits colocalize with RNA polymerase II and regulate transcription in cardiac fibroblasts
Shahriar M Khan, Ryan D Martin, Andrew Bayne, et al.
Health Technology Assessment (Winchester, England)
|
November 29, 2021
Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT
Larisa Duffy, Caroline S Clarke, Gemma Lewis, et al.
Journal of Medicinal Chemistry
|
October 7, 2014
Circumventing seizure activity in a series of G protein coupled receptor 119 (GPR119) agonists
James S Scott, Suzanne S Bowker, Katy J Brocklehurst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 18, 2020
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial
P Grimison, A Mersiades, A Kirby, et al.
Page
of 86